The optimal end-tidal sevoflurane concentration for successful ProSeal™ (Teleflex, Morrisville, NC, USA) laryngeal mask airway (PLMA) versus Classic™ (Teleflex, Morrisville, NC, USA) laryngeal mask airway (CLMA) insertion in unpremedicated anaesthetised adults is unknown. We determined end-tidal sevoflurane concentrations for successful insertion in fifty percent of anaesthetised adults. This randomised, prospective, double-blind study was conducted in the operating theatre of a government tertiary care hospital. Forty-four unpremedicated American Society of Anesthesiologists physical status I and II women with cervical carcinoma (aged 30 to 60 years), scheduled for intracavity caesium implantation under general anaesthesia with a laryngeal mask airway (LMA) were included in the study. The participants were randomised to one of the two groups, to receive either a PLMA or CLMA. After anaesthetic induction with sevoflurane, a predetermined end-tidal sevoflurane concentration (starting at 2.5%) was sustained for 10 minutes before LMA insertion was attempted. End-tidal sevoflurane concentration was increased/decreased (step-size 0.25%) using Dixon and Massey's up-and-down method for the next patient based on the previous patient's response. Placement without clenching, movement, coughing or biting within one minute was considered successful insertion. The end-tidal sevoflurane concentration required for successful LMA insertion in fifty percent of anaesthetised adults was calculated as the mean of the crossover pairs' midpoints in each group and further confirmed by probit regression analysis. The end-tidal sevoflurane concentration (95% confidence interval) required for successful PLMA insertion in 50% of anaesthetised adults (3.15% [3.12% to 3.18%]) was significantly higher than that for CLMA insertion (2.71% [2.66% to 2.76%], P <0.001). These findings suggest that deeper anaesthesia is required for placement of a PLMA in comparison to a CLMA.
The ProSeal™ (Teleflex, Morrisville, NC, USA) laryngeal mask airway (PLMA) was introduced around a decade ago to overcome the perceived shortcomings of the Classic TM (Teleflex, Morrisville, NC, USA) laryngeal mask airway (CLMA), such as the lack of protection against aspiration and a low pressure seal 1 . However, the PLMA is larger and more rigid than the CLMA 2,3 . For these reasons, there may be a higher anaesthetic requirement for insertion of the PLMA than the CLMA. The 50% effective concentration (EC 50 ) of propofol for PLMA insertion is reported to be 38% to 50% higher compared to that for CLMA insertion, depending on the use of premedication 3, 4 .
Despite propofol being frequently used for induction of general anaesthesia in adults, there are some circumstances in adults (such as patients with difficult IV access, anxious patients not allowing IV access and an anticipated difficult airway) in which sevoflurane inhalational induction is a viable alternative for induction and insertion of LMA due to the favourable pharmacological properties of sevoflurane [5] [6] [7] [8] .
The comparative EC 50 of sevoflurane for CLMA and PLMA insertion has been evaluated in one study, which reported that it was higher for the PLMA 4 . However, in that study, premedication with 2 mg of intramuscular midazolam and use of a size 3 laryngeal mask airway (LMA) in all of the study subjects, irrespective of their weight and size, might have influenced the EC 50 determination.
This study was undertaken to calculate the comparative EC 50 and 95% effective end-tidal concentration (EC 95 ) of sevoflurane required for PLMA and CLMA insertion in unpremedicated anaesthetised adults. As we studied end-tidal concentrations, the terms sevoflurane ET% 50 and ET% 95 will be used.
Materials and methods
The study was set in a public tertiary care hospital in India. The Consolidated Standards of Reporting Trials (CONSORT) guidelines were followed 9 Sixty-five consecutive females of American Society of Anesthesiologists physical status I and II, 30 to 60 years of age, with cervical carcinoma and undergoing implantation of intracavity caesium under general anaesthesia were screened for study inclusion (Figure 1 ).
Exclusion criteria included patients with an anticipated difficult airway, body mass index >35 kg/m 2 , mouth opening <2.5 cm, cervical spine disease, respiratory tract infection, patients at risk of aspiration and patients with neuromuscular or cardiovascular disease. The study subjects were kept nil by mouth for eight hours for solid food and six hours for fluids. Patients did not receive premedication.
Randomisation and allocation concealment
Patients were randomised to either the CLMA group or the PLMA group using random numbers generated by randomrandomiser software in blocks of six, and allocation was by means of sealed envelopes opened by an assistant not involved in the study. An anaesthetist with experience in placing 200 CLMAs and more than 50 PLMAs, and who was unaware of the sevoflurane concentration, inserted the LMA.
Anaesthesia protocol
Anaesthesia was induced with sevoflurane (in 100% oxygen), this being increased in incremental fashion, via facemask through a semi-closed circuit system, to a concentration of 8%. After the disappearance of the eyelash reflex, while the patient spontaneously ventilated, the vaporiser was adjusted to achieve an end-tidal sevoflurane concentration (ET SEVO ) at the predetermined level. In each subject, predetermined target end-tidal concentrations were maintained for a minimum of ten minutes by adjusting the vaporiser settings, following which either a PLMA or CLMA was placed according to randomisation. This period was chosen because it has been reported that four to eight minutes are required to attain more than 90% brain partial pressure equilibrium with arterial sevoflurane 4 . The size of LMA was chosen according to the manufacturer's recommendation. Lubricant gel was applied at the back of the LMA cuff and all were inserted in a deflated state. The CLMA was placed without an introducer and the PLMA using an introducer. The LMA cuff was inflated to 55 to 60 cmH 2 O after insertion. Airway patency was judged clinically by visualising adequate bag movements and chest inflation, and capnography was used to assess the adequacy of ventilation.
Sevoflurane concentrations
The target ET SEVO for the first subject in each group was 2.5%, this value being based on a previous report 4 . The ET SEVO for the next patient was decided on using Dixon and Massey's up-and-down method 10,11 using 0.25% as the stepsize. The ET SEVO was increased or decreased in subsequent patients depending on the previous patient's response, as assessed by an observer who was masked to the sevoflurane concentration. The patients were observed for one minute after the LMA placement and evaluated for 'movement' or 'no movement'. 'Movement' was defined as difficulty in mouth opening during LMA placement, coughing, gagging, clenching/biting of teeth, breath holding, laryngospasm or purposeful movement of the extremities. Movement was considered an unsuccessful attempt at placement. If the LMA placement was unsuccessful then the anaesthetic depth was immediately increased by raising the sevoflurane concentration to 8% or by administering IV propofol (0.5 mg/kg, in incremental doses if required) and the LMA was reinserted once adequate depth of anaesthesia had been achieved. If the LMA placement was unsuccessful, the next patient received an increment in the target ET SEVO concentration. If insertion was successful, the next patient received a decrement in the concentration. This process was continued until the predetermined numbers of crossover points (eight pairs) had been obtained in either group. The midpoint was defined as the average ET SEVO concentration of crossover (movement/no movement) responses.
Intraoperatively, patients were monitored for electrocardiogram, respiratory rate, non-invasive blood pressure, pulse oximetry, bispectral index score, capnography and ET SEVO concentration using multichannel monitors (Datex-Ohmeda S/5 Avance, GE Healthcare, Madison WI, USA).
Primary and secondary outcomes
The primary outcome was the ET% 50 of sevoflurane for successful LMA placement. Secondary outcomes were the incidence of coughing, gagging, breath holding, laryngospasm, clenching of teeth/ biting and purposeful movement of the extremities. All study subjects were interviewed in the recovery room to assess memory recall. Other adverse events were recorded.
Statistical analysis
Patients' characteristics are presented as mean and standard deviation or number. Continuous variables were analysed by t-test and categorical variables by chi-square test. The primary variable was the sevoflurane ET% 50 for successful CLMA and PLMA insertion. The average of the midpoints of all movement and no-movement pairs was used to calculate the ET% 50 using Dixon and Massey's up-and-down method. Dose-response curves for sevoflurane ET% 50 and ET% 95, with 95% confidence intervals (CI), were determined by probit regression. Analysis was performed using Excel 2007 (Microsoft, Redmond, WA, USA) and SPSS version 15.0 software (IBM, Armonk, NY, USA).
Results
Participant flow is depicted in Figure 1 . A total of 65 patients were screened for inclusion in the study, of whom 44 were randomised to either the CLMA (n=21) or PLMA (n=23) group. There were no significant differences between groups in terms of demographic data or LMA size ( Table 1 ).
Evaluation of efficacy
The sequences of patients with successful and unsuccessful CLMA (n=21) and PLMA (n=23) insertion are shown in Figures  2 and 3 . The required mean (standard deviation) ET% 50 of sevoflurane calculated using the up-and-down method was significantly higher for successful PLMA insertion (3.12% [0.23]) as compared to CLMA insertion (2.72% [0.28], P <0.001). Using probit analysis, dose response curves for CLMA and PLMA insertions were plotted (Figure 4) . These confirmed results, the ET% 50 (95% CI) for PLMA insertion being 3.15% (3.12 to 3.18) and for CLMA insertion 2.71% (2.66 to 2.76). The ET% 50 of sevoflurane required for PLMA insertion was 1.16% (CI 1.03 to 1.59) higher than that required for the CLMA. The predicted ET% 95 (95% CI) by extrapolation for PLMA insertion was 3.44 % (3.39 to 3.51) versus 3.22% (3.14 to 3.33) for CLMA insertion ( Table 2) . No patient required a change of LMA size or endotracheal intubation. Episodes of movement during insertion are shown in Table 3 . There were no episodes of hypotension and Values are expressed as number (percentage). PLMA=ProSeal laryngeal mask airway, CLMA=Classic laryngeal mask airway.
Concentration (%)
Filled circles represent no movements while hollow circles represent movement. haemodynamic data were comparable between the groups. No patient reported recall.
Discussion
In unpremedicated anaesthetised adult females we found the sevoflurane ET% 50 and ET% 95 for PLMA placement to be 3.15% and 3.44%, respectively, this being significantly higher (by 15%) than that of the ET% 50 and ET% 95 for CLMA placement (2.72% and 3.22%, respectively).
Previous studies found that insertion of a PLMA may take longer and require more attempts 12, 13 . The difference in insertion technique due to design variations may explain the variable success rates. This study was conducted in female patients with cervical carcinoma undergoing caesium implant placement. Many had previously received chemotherapy and had difficult venous access due to thrombosed or fragile veins. In this scenario, sevoflurane induction and maintenance of anaesthesia is a viable clinical alternative.
The ET% 50 of sevoflurane required for CLMA and PLMA insertion was compared by Kodaka et al 4 . They observed the ET% 50 for PLMA placement to be 20% higher (2.82% [0.45]) than that for CLMA placement (2.36% [0.22]). Our results were similar, with movement-free PLMA placement needing 15% more sevoflurane. However, the ET% 50 for both groups was higher in our study, probably because premedication (midazolam 2 mg intramuscularly) was used in the Kodaka et al study. This might have decreased requirements. In addition, their patients all had a size 3 LMA while we chose the size according to the manufacturer's recommendation.
The ET% 50 of sevoflurane for CLMA placement in our study was also found to be higher than that in a study by Tanaka et al 14 (2.72% versus 2.0%). This difference might have been due to differences in patient age and methodology. Tanaka et al allowed spontaneous ventilation initially, later provided gentle manual controlled ventilation and allowed more time (20 minutes) for equilibration prior to placement. They used a step-size of 0.5%, which was a quarter of the sevoflurane concentration used in their first patient. A step-size of 10% of the first concentration, as used in this study, obtains the most accurate results using the up-and-down method 15 .
We found that the ET% 50 of sevoflurane needed was approximately 15% more for the PLMA as compared to the CLMA, which is less than the difference associated with propofol (38% to 50%) 4 . This may be because sevoflurane appears better at blocking noxious stimuli than propofol 16 .
One limitation of the present study was that it included only females of American Society of Anesthesiologists status I and II, so we can only speculate about the results in different populations. Secondly, an experienced person placed all the devices and our results might not apply to those with less experience. Also, a volatile-only induction technique is not common in adults and the introduction of opioids before insertion might reduce the ET% 50 . Further research with the addition of opioids and a shorter equilibration time is warranted. Another limitation is that, although probit analysis provides a useful estimate of range, this design underestimates the range 17 .
Conclusion
In conclusion, we found that the sevoflurane ET% 50 concentration for insertion of a PLMA was 15% higher than that for insertion of a CLMA in unpremedicated anaesthetised female adults. This suggests that deeper anaesthesia is required for PLMA, in comparison to CLMA, placement.
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